myPatientSpace
- Company typePrivate
- Founded2017
- HeadquartersMalahide, Ireland
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
myPatientSpace firmographics
Firmographics- Name
- myPatientSpace
- Legal name
- myPatientSpace Limited
- Website
- https://mypatientspace.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
myPatientSpace industry classification
Industry- Product category
- Digital Health Software Platform
- NAICS
- Ambulatory Health Care Services (621)
- SIC
- Services-Computer Programming, Data Processing, Etc. (7370)
- akta.pro primary industry
- Hospital-at-Home & Acute Virtual Care Platforms (HLALABAC)
- akta.pro secondary industries
- Post-Acute & Transitional Care Virtual Platforms (SNF/home health coordination) (HLALABAG), Medical-Grade Device Connectivity & Device Management (MDM) (HLACAFAG), Virtual Specialty Care Platforms (tele-stroke, tele-ICU, tele-derm, tele-cardiology) (HLALABAD)
Keywords
Where myPatientSpace is headquartered
LocationHeadquarters
- HQ city
- Malahide
- HQ country
- Ireland
- HQ region
- Europe
Offices2 records
Markets served
myPatientSpace business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- SaaS Platform Subscription: myPatientSpace operates as a SaaS platform providing subscription-based access to their Digital Health as a Service platform. Healthcare providers, life sciences companies, and government healthcare systems subscribe to the platform to deploy customized digital health programs. The subscription model includes User Subscriptions, Software access, and Documentation as described in their standard terms.
- Professional Services: Additional professional services including implementation, configuration, integration with hospital systems, and custom development. Professional services are invoiced separately from subscription fees and include acceptance testing processes.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise SaaS subscription with configurable modules |
| Per seat | Annual | User subscription model with per-user licensing |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
myPatientSpace product offering
Product offeringCore offering
myPatientSpace provides a medical-grade Digital Health as a Service (DHaaS) platform that enables healthcare providers, life sciences companies, and government health systems to rapidly deploy customised digital health programs. The platform bundles telehealth, remote patient monitoring, patient-reported outcome measures, smart triage and alerts, scheduling, and analytics into configurable modules, with pre-built therapeutic solutions for COPD, chronic kidney disease, sleep apnoea, oncology, chronic pancreatitis, and rural health. The platform is CE-marked as a Class IIa medical device and is sold on an annual subscription basis with separately invoiced implementation and integration services.
Product overview
myPatientSpace is a comprehensive Digital Health as a Service (DHaaS) platform offering a modular portfolio of solutions. The core offering consists of the myPatientSpace DHaaS Platform, the myPatientSpace Patient App, and myStaffSpace staff portal. The platform provides configurable modules including Telehealth and Virtual Care, Remote Patient Monitoring, Smart Triage and Alerts, and Scheduling and Clinic Management. Named solutions built on the platform include CARE Virtual Ward for respiratory care, SmartCP for chronic pancreatitis, the Melanoma Ireland App, MAC Study for oncology research, the ResMed PEI Sleep Apnoea Solution, the CKD/Renal App, Virtual OSA Pathway, and the Healthy Islands Project for rural health. The platform supports multiple therapy areas including Oncology, Respiratory, Sleep, Rheumatology, and Chronic Kidney Disease, and is CE-marked as a Class IIa medical device.
Differentiator
Problem solved
Functional benefit
Products and services
- myPatientSpace DHaaS Platform Comprehensive, medical-grade Digital Health as a Service platform that is customisable for any therapy area using modules and pre-packaged solutions; supports telehealth, remote patient monitoring, analytics, scheduling, and workflow automation for healthcare providers, life sciences companies, and government health systems.
- myPatientSpace Patient App
Quantifiable outcome
- 934 hospital bed days saved and €4.2M+ estimated healthcare value through CARE Virtual Ward COPD program
- +7 more outcomes
Companies that use myPatientSpace
Customer profileNamed customers10 records
Segments3 records
Ideal customer profiles3 records
myPatientSpace technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature11 records
myPatientSpace partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core and strategic.
- bioMérieuxcorePartnership to develop the Smart CP solution for chronic pancreatitis patients. bioMérieux is a French multinational biotechnology company specializing in in vitro diagnostics. The Smart CP platform was developed in collaboration with Shirley Potter and Kelsey O'Donnell for the Melanoma Ireland initiative, though bioMérieux connection relates to the Smart CP chronic pancreatitis solution.
- ResMed PEIcoreResMed PEI delivers a managed care service for patients on ResMed CPAP devices in Ireland. All patients in Ireland on the ResMed PEI managed care service use the myPatientSpace platform for therapy monitoring, patient compliance, and clinical support.
- CiscostrategicCisco partnered with University of Galway to bring 5G connectivity to Clare Island in Ireland. myPatientSpace is the platform of choice for this telehealth-driven project enabling digital inclusion and access to quality care for remote communities.
- Tallaght University HospitalcoreCo-development partnership for Smart CP chronic pancreatitis platform. Tallaght University Hospital (affiliated with Trinity College Dublin) developed the app for remote patient management. Won European Hospital Management Innovation Award and Best Digital Health Innovation Award at HSE Spark Summit 2026.
- University of Galway (HIVE Lab)coreResearch partnership with the HIVE Laboratory at University of Galway for COPD Virtual Ward development. Won Irish Healthcare Centre Award for Best Use of Information Technology 2025 and National HealthTech Innovation Award for Healthcare Collaboration.
- Health Service Executive (HSE) IrelandcoreDigital Transformation partnership with HSE Digital Transformation Office. myPatientSpace is implementing solutions across main Dublin hospitals and clinical areas. HSE Director of Digital Transformation Prof. Martin Curley endorses the platform for scalability across Irish healthcare.
- St. James's Hospital DublincoreLong-term deployment for remote management of 2700+ CKD patients with integration to national renal system. Also hosts Virtual Obstructive Sleep Apnoea pathway. Platform has enabled new models of care across the Renal journey.
- RCSI Hospitals GroupstrategicLive deployment in OECI cancer centers for remote patient management. Partnership includes MAC Study for menopause after cancer published in PubMed, and oncology deployments across multiple cancer types.
- Our Lady of Lourdes Hospital DroghedastrategicOncology & Haematology deployment plus Stroke Early Supported Discharge pathway. Won National HealthTech Innovation Award for Most Transformative Impact (Digital Health) 2025 and HSE Spark Design Award for Best Design Led Project.
- Letterkenny University HospitalcoreCARE Virtual Ward - Ireland's first 20-bed digitally enabled respiratory service for COPD patients. Saved 934 bed days and delivered €4.2M+ estimated healthcare value. Won HSE Excellence Award 2024 for Improving Patient Experience.
- Geronte EU Project ConsortiumstrategicSelected to participate in EU Horizon 2020 Geronte project - a groundbreaking initiative revolutionizing Geriatric Oncology care in collaboration with expert groups and top institutions across Europe.
- AWS (Amazon Web Services)coreCloud infrastructure provider. Customer data is stored on Amazon AWS or Microsoft Azure in regional data centers. For European customers, data is stored in Ireland and Germany. AWS is also used for SMS messaging services.
- Microsoft AzurecoreCloud infrastructure provider. Data storage and processing on Azure cloud platform alongside AWS. Part of the enterprise-grade infrastructure supporting the medical-grade platform.
Scale indicators11 records
Recent moves7 records
Expansion highlights6 records
myPatientSpace competitors and assessment
Company assessmentOthers
- ORCHA (Organisation for the Review of Care and Health Apps): UK-based digital health evaluation and accreditation body that has certified myPatientSpace's apps. Relevant as ecosystem partner for health-system procurement and as a comparator for go-to-market channels in public-sector digital health.
Direct peers
- Huma (formerly Medopad): Digital health platform offering remote patient monitoring, virtual wards, and decentralised clinical trials to hospitals and life sciences companies. Highly comparable in target segments (providers and pharma) and modular platform approach.
- Doccla: UK-based virtual ward and remote patient monitoring provider serving NHS trusts with hospital-at-home services for COPD and other chronic conditions. Closely mirrors myPatientSpace's provider-integrated virtual care model and therapy-area focus.
- Health Recovery Solutions: US-based RPM and care transitions platform used by hospitals to reduce readmissions and manage chronic disease patients at home. Overlapping value proposition in reducing COPD readmissions and post-acute care coordination.
- Current Health (Best Buy Health): Acquired by Best Buy Health, offering an enterprise RPM and hospital-at-home platform with continuous monitoring and clinical oversight. Comparable in targeting large hospital systems with end-to-end virtual care delivery.
- Luscii: Netherlands-based remote monitoring and virtual ward platform acquired by Philips, powering hospital-at-home programs across European health systems. Directly comparable to myPatientSpace's CARE Virtual Ward and CKD/Sleep remote monitoring use cases.
- Biofourmis: Hospital-at-home and RPM platform with FDA-cleared AI algorithms and continuous vital sign monitoring. Comparable in clinical-grade virtual care positioning, device integration, and enterprise health system GTM.
- Vivify Health: Connected health platform providing remote patient monitoring, care pathways, and BYOD device support for health systems and payers. Overlaps with myPatientSpace in configurable care plans and multi-condition RPM.
Broad incumbents
- Philips Remote Patient Monitoring: Large incumbent with a broad RPM and clinical informatics portfolio (now including Luscii), competing for the same European hospital-at-home and chronic care contracts as myPatientSpace.
- Tunstall Healthcare: Established UK-headquartered telehealth and telecare provider offering a broad portfolio across remote monitoring, clinical telehealth, and digital health services to public-sector health systems across Europe.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
myPatientSpace social profiles
Digital presencemyPatientSpace compliance and trust
Trust signalCompliance5 records
myPatientSpace financial estimates
Financial estimateRevenue estimate
Valuation estimate
myPatientSpace leadership team
Management profileNumber of profiles
Profiles1 record
myPatientSpace funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
myPatientSpace M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about myPatientSpace
What does myPatientSpace do?
myPatientSpace provides a medical-grade Digital Health as a Service (DHaaS) platform that enables healthcare providers, life sciences companies, and government health systems to rapidly deploy customised digital health programs. The platform bundles telehealth, remote patient monitoring, patient-reported outcome measures, smart triage and alerts, scheduling, and analytics into configurable modules, with pre-built therapeutic solutions for COPD, chronic kidney disease, sleep apnoea, oncology, chronic pancreatitis, and rural health. The platform is CE-marked as a Class IIa medical device and is sold on an annual subscription basis with separately invoiced implementation and integration services.
Is myPatientSpace a public or private company?
myPatientSpace is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was myPatientSpace founded?
myPatientSpace was founded in 2017. It employs 1 to 10 people.
Where is myPatientSpace based?
myPatientSpace is headquartered in Malahide, Ireland, in the Europe region.
How does myPatientSpace make money?
Two revenue lines are on record. SaaS Platform Subscription is the primary driver. The others are professional Services.
Who are myPatientSpace's main competitors?
ORCHA (Organisation for the Review of Care and Health Apps) is listed as an others. Direct peers are Huma (formerly Medopad), Doccla, Health Recovery Solutions, Current Health (Best Buy Health), Luscii, Biofourmis and Vivify Health. Broad incumbents are Philips Remote Patient Monitoring and Tunstall Healthcare.
Does myPatientSpace have an API?
No public API is recorded for myPatientSpace.
What industry is myPatientSpace in?
myPatientSpace's product category is Digital Health Software Platform. Its primary akta.pro industry code is HLALABAC, Hospital-at-Home & Acute Virtual Care Platforms, with a secondary code of HLALABAG, Post-Acute & Transitional Care Virtual Platforms (SNF/home health coordination). Its NAICS code is 621 and its SIC code is 7370.